Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age
- PMID: 11490143
- DOI: 10.1159/000052808
Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age
Abstract
Background: Secretory leukocyte protease inhibitor (SLPI) exhibits antimicrobial activities that, in addition to other well-characterized proteins such as lysozyme and lactoferrin, is thought to play a critical role in mucosal defenses. Although elderly individuals are particularly susceptible to mucosal infections, salivary production of SLPI has not been assessed in an aged cohort.
Objectives: Hypothesizing that oral SLPI concentrations are reduced with advanced age, this cross-sectional study compared SLPI concentrations to concentrations of lysozyme, lactoferrin and total protein in unstimulated salivary secretions of healthy, community-dwelling 79+-year-old and younger adults.
Methods: Study participants were 45 non-hospitalized dentate adults aged 79-89 (23 elderly) or 21-51 years (22 non-elderly). Home-based interviews and clinical examinations determined dentate status and confirmed the absence of dentures, oral mucosal disease, anti-infective medication use, irradiation therapy for head and neck cancer and self-perceived xerostomia. Whole unstimulated saliva was collected from all subjects and analyzed for antimicrobial protein concentration by enzyme-linked immunosorbent assay and for total protein content by the bicinchoninic acid method. Bivariate and multivariate (generalized linear modeling) analyses evaluated the relationships between age, gender and salivary protein concentrations.
Results: Mean salivary levels of SLPI and lysozyme were lower in elderly compared with non-elderly subjects (p < 0.001), unlike lactoferrin and total protein levels. Similar results were obtained when concentrations of the individual proteins were normalized to the total protein concentration, suggesting that glandular production of SLPI and lysozyme preferentially decreases with aging. Gender differences were detected only for SLPI concentrations; males had lower SLPI levels than females regardless of age (p < 0.01). Generalized linear models confirmed that age (p < 0.001) and gender (p < 0.05) were each associated with the SLPI concentration and together accounted for 50% of the variation in SLPI concentration in this population.
Conclusion: These findings indicate that SLPI production is diminished among healthy community-dwelling older adults, particularly elderly males. Further investigation should determine the impact of decreased local SLPI production on the increased risk of oral mucosal disease with advanced age.
Copyright 2001 S. Karger AG, Basel
Similar articles
-
Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.Oral Oncol. 2016 Apr;55:1-5. doi: 10.1016/j.oraloncology.2016.02.004. Epub 2016 Feb 24. Oral Oncol. 2016. PMID: 27016010 Free PMC article.
-
Salivary secretory leukocyte protease inhibitor increases in HIV infection.J Oral Pathol Med. 2004 Aug;33(7):410-6. doi: 10.1111/j.1600-0714.2004.00218.x. J Oral Pathol Med. 2004. PMID: 15250833
-
Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.Infect Immun. 2004 Apr;72(4):1956-63. doi: 10.1128/IAI.72.4.1956-1963.2004. Infect Immun. 2004. PMID: 15039315 Free PMC article.
-
Endogenous salivary inhibitors of human immunodeficiency virus.Arch Oral Biol. 1999 Jun;44(6):445-53. doi: 10.1016/s0003-9969(99)00003-5. Arch Oral Biol. 1999. PMID: 10401522 Review.
-
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I.Oral Dis. 1997 May;3 Suppl 1:S64-9. doi: 10.1111/j.1601-0825.1997.tb00377.x. Oral Dis. 1997. PMID: 9456660 Review.
Cited by
-
Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.Infect Immun. 2005 Mar;73(3):1271-4. doi: 10.1128/IAI.73.3.1271-1274.2005. Infect Immun. 2005. PMID: 15731023 Free PMC article. Review. No abstract available.
-
Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.Oral Dis. 2016 Nov;22(8):781-790. doi: 10.1111/odi.12550. Epub 2016 Aug 17. Oral Dis. 2016. PMID: 27470907 Free PMC article.
-
COPD as a Disease of Immunosenescence.Yonsei Med J. 2019 May;60(5):407-413. doi: 10.3349/ymj.2019.60.5.407. Yonsei Med J. 2019. PMID: 31016901 Free PMC article. Review.
-
Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.Oral Oncol. 2016 Apr;55:1-5. doi: 10.1016/j.oraloncology.2016.02.004. Epub 2016 Feb 24. Oral Oncol. 2016. PMID: 27016010 Free PMC article.
-
The Impact of Immunosenescence on Pulmonary Disease.Mediators Inflamm. 2015;2015:692546. doi: 10.1155/2015/692546. Epub 2015 Jun 23. Mediators Inflamm. 2015. PMID: 26199462 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical